Clinical Trials Logo

Pulmonary Disease clinical trials

View clinical trials related to Pulmonary Disease.

Filter by:

NCT ID: NCT06310577 Not yet recruiting - Pulmonary Disease Clinical Trials

Evaluation of Leak-Free Bronchoscope Adapter to Limit Ventilated Air Volume Loss During Bronchoscopy

Start date: April 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to evaluate the ability of a new bronchoscope adapter called "leak-free adapter" to limit the amount of air leaking out to the operating room (OR) from the ventilator in intubated patients who undergo bronchoscopy.

NCT ID: NCT06202586 Recruiting - Pulmonary Disease Clinical Trials

Effect of Different Oxygen Concentration on Postoperative Pulmonary Complications After Pulmonary Reexpansion

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

To evaluate the effect of 80% inspiratory oxygen fraction (FiO2) and 30% FiO2 on the incidence of pulmonary complications after pulmonary reexpansion following one-lung ventilation and 2-hour postoperative within the first 7 days after thoracic surgery, based on lung protective ventilation strategy.

NCT ID: NCT06185842 Active, not recruiting - Pulmonary Disease Clinical Trials

The Effectiveness of a Lung Health Promotion Program Based on the 5A Self Management Support Model.

Start date: November 24, 2023
Phase: N/A
Study type: Interventional

This research will be conducted to examine the effect of the lung health promotion program based on the 5A self-management support model on some physiological parameters, Physical Activity Scale in the Elderly score, sleep quality, health status perception and vaccination status of adults aged 65 and over. The research will be carried out as a randomized controlled study with a parallel design. We estimate that the respiratory functions of the elderly will improve, their physical activity levels will increase, immunization against common infectious diseases will increase and people's health perceptions will improve. with the lung health promotion program based on the 5A self-management support model.

NCT ID: NCT06149494 Recruiting - Copd Clinical Trials

RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection

Start date: November 20, 2023
Phase: Phase 2
Study type: Interventional

Vapendavir (VPV) is a drug being developed to treat human rhinovirus (RV) infection, one virus responsible for the common cold. Vapendavir prevents the virus from entering cells and making more infectious copies of itself. A study is being planned to investigate VPV in patients with chronic obstructive pulmonary disease (COPD, a lung disease making it difficult to breathe) who develop a rhinoviral infection; however, VPV has not been approved for use in treating any indication (disease) by the FDA or any other global regulatory agency. Therefore, VPV is considered investigational, and the study doctor is conducting this investigational research study. Safety will be monitored throughout the entire study.

NCT ID: NCT06108908 Recruiting - Asthma Clinical Trials

Influence of Inhaler Compliance on the Treatment of Asthma Patients

Start date: August 14, 2019
Phase:
Study type: Observational

The major goal of "Influence of Inhaler Compliance on the Treatment of Asthma Patients" is to explore compliance rate outcome in adult asthmatic patients (20-80 years old) with mild to moderate persistent asthma according to American Thoracic Society (ATS) definition and diagnosis. The major endpoints include: 1. To increase the adherence rate of treatment by reminder intervention with correctly monitor patients' adherence rate by Asthma Supportive Kits 2. Eventually achieve best asthma care and management. All participants will use Asthma Supportive Kits for 24 weeks and return visit on week 5, 12, 24. Based on collected data, the study compares intervention and control group to see if active reminder intervention may effectively alter compliance rate, and corresponding outcomes, e.g., asthma control status, acute exacerbation events.

NCT ID: NCT06088485 Recruiting - Cystic Fibrosis Clinical Trials

The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis

Start date: September 5, 2023
Phase:
Study type: Observational

The study was conducted in the age range of 18-45 December, who were diagnosed with Cystic fibrosis.

NCT ID: NCT06087523 Enrolling by invitation - Pulmonary Disease Clinical Trials

Pulmonary Disease Among Patients With Systemic Lupus Erythematosus

Start date: August 15, 2023
Phase:
Study type: Observational

Pulmonary diseases are common among patients with Systemic Lupus Erythematosus (SLE) and associated with a significantly increased morbidity, mortality, and lower self-reported health related quality of life. The investigators aim to diagnose and categorise SLE patients in regards of pulmonary disease and introduce alternative diagnostic tools. The investigators will perform a cross-sectional study of a population-based study population of SLE patients. The participants will undergo review of medical record, a clinical assessment, body plethysmography, six-minute walk test, high-resolution computed tomography of the thorax (HRCT), thoracic and diaphragmatic ultrasound, blood sampling with analysis of autoantibodies, and three questionnaires. After the investigations, pulmonary diseases among the participants will be diagnosed at a multidisciplinary discussion by a specialised pulmonologist with contribution from a rheumatologist and a radiologist. The investigators believe that the study will increase the understanding of pulmonary diseases among SLE patients, which could improve overall disease management. The investigators will introduce new alternative diagnostic tools, that could ease diagnosing pulmonary disease among SLE.

NCT ID: NCT06056882 Recruiting - Pulmonary Disease Clinical Trials

Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules

Start date: September 20, 2023
Phase:
Study type: Observational

It is planned to use the CLE probe and cryoprobe simultaneously after detection of the round focus. It is planned to include 5 patients with suspected central airway invading lung carcinoma and 15 patients with suspected peripheral lung carcinoma who have an indication for bronchoscopic histologic confirmation.

NCT ID: NCT05970848 Not yet recruiting - Pulmonary Disease Clinical Trials

Washing Pipe With a Spray Nozzle for Topical Anesthesia During Bronchoscopy

Start date: July 2023
Phase: N/A
Study type: Interventional

The goal of this randomized control trial is to evaluate the effectiveness and safety of using a spray nozzle, compared to the conventional method, for topical anesthesia by the spray-as-you-go technique in reducing cough frequency, improving cough, discomfort, tolerance, satisfaction, reducing the dosage of lidocaine consumption of patients during flexible bronchoscopy.

NCT ID: NCT05967117 Recruiting - Pulmonary Disease Clinical Trials

Chest CT Using Low-concentration Iodine Contrast Media

Start date: November 24, 2023
Phase: Phase 4
Study type: Interventional

This study aims to evaluate the quality of images when low-concentration iodine contrast agents is used in chest CT with low tube voltage and if they can be used in routine imaging. The primary endpoint of the study was the quality of the image and comparison of chest CT by using low and conventional concentration iodine contrast agents with low tube voltage and chest CT by using the conventional concentration iodine contrast agents with the conventional tube voltage; The secondary endpoint is optimizing chest CT protocol using an iodine contrast agent.